Clinical Trial Record

Return to Clinical Trials

MR Guidance for Liver and Pancreas


2018-07-11


2027-02


2027-02


30

Study Overview

MR Guidance for Liver and Pancreas

This is a single centre, single arm, prospective feasibility study that aims to see whether magnetic resonance imaging (MRI) as a source of image guidance before each radiation treatment fraction is feasible, and also if it may provide information that could potentially be used during the treatment to improve the radiation treatment plan. Patients will have 5 MRIs with each of their RT sessions. If patients' RT treatment will consist of more than 5 fractions, only 5 MRIs will be done with any 5 RT fractions. Patients will be completing a short questionnaire at the end of each MRI. A patient questionnaire will also be completed at the end of the study to assess for patient satisfaction. There will be 30 evaluable patients enrolled to the study.

N/A

  • Magnetic Resonance Imaging
  • OTHER: MRI
  • 18-5176

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates Results Reporting Dates Study Record Updates

2018-05-01  

N/A  

2024-06-17  

2018-06-27  

N/A  

2024-06-18  

2018-07-10  

N/A  

2024-06  

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

Design Details

Primary Purpose:
N/A


Allocation:
N/A


Interventional Model:
N/A


Masking:
N/A


Arms and Interventions

Participant Group/ArmIntervention/Treatment
: Pancreatic Cancer

Approximately 10 patients with pancreatic cancer will be enrolled to the study with the primary aim of determining the feasibility of using off-line MRI-guidance during the course of radiation treatment

OTHER: MRI

  • Patients who consent to this study will have an abdominal MRI prior to or immediately after each fraction of radiation treatment in the case of those patients that are undergoing SBRT or those receiving palliative treatment. On patients receiving definiti
: Liver Metastases

Approximately 10 patients with liver mets will be enrolled to the study with the primary aim of determining the feasibility of using off-line MRI-guidance during the course of radiation treatment

OTHER: MRI

  • Patients who consent to this study will have an abdominal MRI prior to or immediately after each fraction of radiation treatment in the case of those patients that are undergoing SBRT or those receiving palliative treatment. On patients receiving definiti
: Hepatocellular carcinoma

Approximately 10 patients with HCC will be enrolled to the study with the primary aim of determining the feasibility of using off-line MRI-guidance during the course of radiation treatment

OTHER: MRI

  • Patients who consent to this study will have an abdominal MRI prior to or immediately after each fraction of radiation treatment in the case of those patients that are undergoing SBRT or those receiving palliative treatment. On patients receiving definiti
Primary Outcome MeasuresMeasure DescriptionTime Frame
Patient Satisfaction SurveyTo evaluate patient satisfaction with the MR guidance process, a modified version of a questionnaire previously used at our institution will be performed at the end of the studyAt study completion (day5 or week 5, depending on type of treatment)
MRI-Anxiety QuestionnaireThis instrument will be used to evaluate patient related anxiety after each MRPrior to or before MR session 1 (day 1 or week 1, depending on type of treatment)
MRI-Anxiety QuestionnaireThis instrument will be used to evaluate patient related anxiety after each MRPrior to or before MR session 2 (day 2 or week 2, depending on type of treatment)
MRI-Anxiety QuestionnaireThis instrument will be used to evaluate patient related anxiety after each MRPrior to or before MR session 3 (day 3 or week 3, depending on type of treatment)
MRI-Anxiety QuestionnaireThis instrument will be used to evaluate patient related anxiety after each MRPrior to or before MR session 4 (day 4 or week 4, depending on type of treatment)
MRI-Anxiety Questionnairehis instrument will be used to evaluate patient related anxiety after each MRPrior to or before MR session 5 (day 5 or week 5, depending on type of treatment)
Secondary Outcome MeasuresMeasure DescriptionTime Frame

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Name: Edel Sexton

Phone Number: 416-946-4501

Email: Edel.Sexton@uhn.ca

Study Contact Backup

Name: Jana Huang

Phone Number:

Email: Jana.Huang@uhnresearch.ca

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person’s general health condition or prior treatments.

Ages Eligible for Study:
ALL

Sexes Eligible for Study:
18 Years

Accepts Healthy Volunteers:

    Inclusion Criteria:

  • Patients 18 years or older
  • Diagnosed with locally advanced pancreatic cancer or hepatocellular carcinoma being considered for treatment with chemoradiation, long course RT, or SBRT with curative intent or palliative intent, planned for 5 or more RT fractions

  • Exclusion Criteria:
    - Contraindications for MRI: ferromagnetic prosthesis, pacemaker / implanted defibrillator, claustrophobia

Collaborators and Investigators

This is where you will find people and organizations involved with this study.


    • PRINCIPAL_INVESTIGATOR: Laura Dawson, MD, University Health Network, Toronto

    Publications

    The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

    General Publications

    No publications available